secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001140361-23-035093
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics updates legal opinion to cover up to 49M shares under ATM facility
--------------------------------------------------------------------------------

- Filed updated legal opinion with SEC covering sale of up to 49M shares of common stock under existing ATM facility with Cowen.
- Previous opinion covered 38M shares; increase of 11M shares reflects updated capacity under $200M S-3 registration.
- No changes to the Sales Agreement terms; the opinion reaffirms legality of issuance under Securities Act.
- The increased share limit provides additional flexibility for potential capital raises under the existing at-the-market program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123035093/0001140361-23-035093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123035093/brhc20056046_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-035093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer